Skip to main content


Modern medicines can provide many benefits to patients, communities, the health system and wider economy. They work by immunising, treating or curing patients of diseases and illnesses to improve a patient's quality of life.

  • Immunisations have significantly reduced the incidence of the following diseases  – Polio, smallpox, rubella, measles, mumps, tetanus, chicken pox.1
  • Survival rates for metastatic melanoma almost 50% due to advances in immune therapies.2
  • Hepatitis C is now curable in more than 90% of treated patients.3
  • HIV has been transformed from a death sentence to a manageable disease.4,5
  • Asthma deaths halved globally by improvements in medicines.6


Modern medicines also provide savings for the health system downstream...

  • $1 spent on modern type 2 diabetes medicines returns $3 in health/economic benefits and $4.20 in societal benefits.7
  • $1 spent on cancer medicines is $1 saved in the New Zealand health system.8


1. Roush, S. & Murphy, T. (2007). Historical Comparisons of Morbidity and Mortality for Vaccine-Preventable Diseases in the United States. JAMA. Nov 14 2007 (Vol 298 No 18.): 2155-2163.
2. Sznol, M. (2019). Long-Term Survival Outcomes With New Treatments for Advanced Melanoma: Questions Still in Need of Answers. The ASCO Post: 25 Oct 2019. Available here
3. PHRMA. (December 2014). Twenty-five Years of Progress Against Hepatitis C: Setbacks and Stepping Stones. Washington, USA.
4. NHS. (2018). What is the life expectancy for someone with HIV?. Available here (accessed 3 March 2020).
5. Rodger, A. J., et al. (2019). Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. The Lancet, 2019393(39310189), 2428-2438.
6. Beasley, R. & Gibson, P. (2020). Twenty-five years of Respirology: Advances in asthma. Respirology, 25(1), 11-13.
7. PWC (2021). The Economic and Social Cost of Type 2 Diabetes. Wellington, New Zealand.
8. Lichtenberg, F. (2017). The impact of pharmaceutical innovation on the longevity and Hospitalization of New Zealand cancer patients, 1998-2012. (2016) NBER Working Paper. Cambridge, Massachusetts, USA.